Table 4.
In-hospital and long-term outcome of Takotsubo cardiomyopathy in previous studies
| In-hospital mortality n (%) |
Long-term mortality (n,%) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Author, year | Patients F/M n (F%) |
Age (years) | Country | CV death | Other causes | Follow-up (months) | Recurrences n (%) | CV death | Other causes |
| Tsuchihashi et al. (1), 2001 |
88 76/12 (86) |
67±13 | Japan | 1 (1) |
0 | 13±14 | 2 (2.7) |
1 (1.3) |
0 |
| Elesber et al. (38), 2007 |
100 95/5 (95) |
66±13 | USA | 2 (1) |
0 | 26±12 | 10 (11.4) |
7 (7) |
10 (10) |
| Burgdorf et al. (39), 2008 |
50 47/3 (94) |
70±10 | Europe | 0 | 3 (6) |
35±19 | – | 3 (6) |
3 (6) |
| Eshtehardi et al. (40), 2009 |
41 35/6 (85) |
65±11 | Europe | 0 | 0 | 23±10 | 2 (5) |
0 | 1 (2.4) |
| Regnante et al. (41), 2009 |
70 67/3 (95) |
67±11 | USA | 1 (1.4) |
0 | 12 | 2 (2.9) |
0 | 2 (2.9) |
| Sharkey et al. (7), 2010 |
136 130/6 (96) |
68±13 | USA | 2 (1.5) |
1 (0.7) |
27.6±24 | 7 (5) |
0 | 17 (12.5) |
| Previtali et al. (42), 2011 |
132 125/7 (98) |
67±11 | Europe | 1 (0.8) |
0 | 13 | 2 (1.5) |
0 | 1 (0.8) |
| Parodi et al. (5), 2011 |
116 106/10 (91) |
73±10 | Italy | 1 | 1 | 24±15 | 2 | 7 (6) | 4 (3) |
| Eitel et al. (43), 2011 |
256 227/29 (89) |
69±12 | Europe/ North America |
3 (1.1) |
1 (0.4) |
1 to 6 | – | 2 (0.8) |
2 (0.8) |
| Samardhi et al. (20), 2012 |
52 51/1 (98) |
64 (43–89) |
Australia | 0 | 0 | 32.66 | 0 | 0 | 0 |
| Looi et al. (44), 2012 |
100 95/5 (95) |
65±11 | New Zealand | 1 (1) |
0 | 36±20 | 7 (7) |
0 | 4 (4) |
| Cacciotti et al. (45), 2012 |
75 73/2 (97.3) |
71.9±9.6 | Europe | 0 |
0 | 26.4±24 | 1 (1.3) |
2 (2.6) |
0 |
| Song et al. (46), 2012 |
137 101/36 (74) |
59 | Korea | 0 | 0 | 68.4 | 0 | 0 | 9 (6.5) |
| Núñez-Gil et al. (23), 2012 |
100 89/11 (89) |
68±13 | Spain | 0 | 0 | 46 | 4 (4) |
3 (3) |
3 (3) |
| Buja et al. (47), 2012 |
54 47/7 (87) |
72.1 | Italy | 1 (1.85) |
1 (1.85) |
18.5 | 2 (3.9) |
2 (3.9) |
2 (3.9) |
| Weihs et al. (21), 2013 |
179 168/11 (94) |
69±11 | Austria | 1 (0.6) |
– | 36.5±18.9 |
4 (2) |
3 (1.6) |
10 (5.5) |
| Ribeiro et al. (22), 2014 |
37 35/2 (94) |
63±13 | Portugal | 0 | 0 | 16±17 |
0 | 1 (2.8) |
0 |
| Vizzardi et al. (48), 2015 |
42 100 (100) |
67±11 | Italy | 0 | 0 | 12 | 0 | 0 | 0 |
| Redfors et al. (8) 2015 |
302 255/47 (84%) |
66±12 | Sweden |
(4) |
36 | 0 | (12) | ||
| Templin et al. (30) 2015 |
1,750 1,571/179 (89.9%) |
66.4±13.1 | Switzerland | 77 (4.1%) |
12 | 1.8% per year | 5.6% per year | ||
| Gopalakrishnan et al (49) 2015 |
56 45/11 (80.4%) |
65.8±14.12 | USA | 5 Not specified |
27.6±21,6 | not reported | 10 Not specified |
||
| Present study |
55 43/5 (89%) |
68.2±11.4 | Italy | 1 | 2 | 69.6±32.2 | 6 | 0 | 5 |
CV=cardiovascular; F=female; M=male.